387464001: Phenylpropanolamine (substance)

SNOMED CT Concept\Substance\...

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Autonomic agent (substance)\Sympathomimetic agent (substance)\Phenylpropanolamine (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Respiratory system agent (substance)\Cough AND/OR decongestant agent (substance)\Decongestant (substance)\Phenylpropanolamine (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amine and/or amine derivative\Amine (substance)\Amino alcohol\Alkanolamine (substance)\Propanolamine (substance)\Phenylpropanolamine (substance)

\Organic compound\Organic nitrogen compound\Amine and/or amine derivative\Amine (substance)\Amino alcohol\Alkanolamine (substance)\Propanolamine (substance)\Phenylpropanolamine (substance)
\Organic compound\Substance with alcohol structure (substance)\Amino alcohol\Alkanolamine (substance)\Propanolamine (substance)\Phenylpropanolamine (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1461642010 Phenylpropanolamine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1481555013 Phenylpropanolamine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

4500111000005117 Phenylpropanolamin da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Phenylpropanolamine (substance)	Is a	Sympathomimetic agent (substance)	true	Inferred relationship	Some
Phenylpropanolamine (substance)	Is a	Decongestant (substance)	true	Inferred relationship	Some
Phenylpropanolamine (substance)	Is a	Propanolamine (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Phenylpropanolamine measurement	Component	True	Phenylpropanolamine (substance)	Inferred relationship	Some	1
brompheniraminmaleat + dextromethorphanhydrobromid + phenylpropanolaminhydrochlorid 2 mg/5 ml 10 mg/5 ml 12,5 mg/5 ml syrup	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylpropanolamine (substance)	Inferred relationship	Some
Product containing precisely phenylpropanolamine 75 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylpropanolamine (substance)	Inferred relationship	Some
Product containing precisely clemastine 1.34 milligram and phenylpropanolamine 75 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylpropanolamine (substance)	Inferred relationship	Some
Product containing precisely cyclopentolate hydrochloride 2 milligram/1 milliliter and phenylephrine hydrochloride 10 milligram/1 milliliter conventional release eye solution (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylpropanolamine (substance)	Inferred relationship	Some
Phenylpropanolamine hydrochloride	Is a	False	Phenylpropanolamine (substance)	Inferred relationship	Some
Product containing phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	1
clemastin + phenylpropanolamin 0,5/25 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylpropanolamine (substance)	Inferred relationship	Some
Product containing clemastine and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	2
clemastinfumarat + phenylpropanolaminhydrochlorid + paracetamol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylpropanolamine (substance)	Inferred relationship	Some
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylpropanolamine (substance)	Inferred relationship	Some
Product containing chlorphenamine and paracetamol and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	2
Product containing chlorphenamine and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	2
Product containing guaifenesin and phenylephrine and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	2
Product containing dextromethorphan and guaifenesin and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	2
Product containing guaifenesin and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	1
Product containing hydrocodone and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	2
Phenylpropanolamine + carmiphen	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylpropanolamine (substance)	Inferred relationship	Some
brompheniraminmaleat + phenylpropanolamin	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylpropanolamine (substance)	Inferred relationship	Some
brompheniraminmaleat + phenylephrin + phenylpropanolamin	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylpropanolamine (substance)	Inferred relationship	Some
Product containing precisely phenylpropanolamine 75 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylpropanolamine (substance)	Inferred relationship	Some	1
Product containing precisely phenylpropanolamine 75 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	1
Product containing precisely clemastine 1.34 milligram and phenylpropanolamine 75 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylpropanolamine (substance)	Inferred relationship	Some	2
Product containing precisely clemastine 1.34 milligram and phenylpropanolamine 75 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	2
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylpropanolamine (substance)	Inferred relationship	Some	1
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	1
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Phenylpropanolamine (substance)	Inferred relationship	Some	2
Product containing precisely chlorphenamine maleate 4 milligram and mepyramine maleate 25 milligram and phenylephrine hydrochloride 10 milligram and phenylpropanolamine 50 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Phenylpropanolamine (substance)	Inferred relationship	Some	1
Product containing precisely chlorphenamine maleate 4 milligram and mepyramine maleate 25 milligram and phenylephrine hydrochloride 10 milligram and phenylpropanolamine 50 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylpropanolamine (substance)	Inferred relationship	Some	4
Product containing precisely chlorphenamine maleate 4 milligram and mepyramine maleate 25 milligram and phenylephrine hydrochloride 10 milligram and phenylpropanolamine 50 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Phenylpropanolamine (substance)	Inferred relationship	Some	4
Phenylpropanolamine hydrochloride	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Phenylpropanolamine (substance)	Inferred relationship	Some
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Phenylpropanolamine (substance)	Inferred relationship	Some	2
Product containing precisely chlorphenamine maleate 4 milligram and mepyramine maleate 25 milligram and phenylephrine hydrochloride 10 milligram and phenylpropanolamine 50 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Phenylpropanolamine (substance)	Inferred relationship	Some	1
Product containing precisely clemastine 1.34 milligram and phenylpropanolamine 75 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Phenylpropanolamine (substance)	Inferred relationship	Some	2
Clemastine- and phenylpropanolamine-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	2
Product containing chlorphenamine and mepyramine and phenylephrine and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	4
Product containing chlorphenamine and mepyramine and phenylephrine and phenylpropanolamine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	4
Product containing clemastine and paracetamol and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	2
Product containing precisely phenylpropanolamine 75 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Phenylpropanolamine (substance)	Inferred relationship	Some	1
Product containing clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	2
Phenylpropanolamine-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	1
Allergy to phenylpropanolamine (finding)	Causative agent	True	Phenylpropanolamine (substance)	Inferred relationship	Some	1
Chlorphenamine and phenylpropanolamine only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	2
Clemastine and paracetamol and phenylpropanolamine only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	2
Product containing only clemastine and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	2
Product containing only chlorphenamine and mepyramine and phenylephrine and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	4
Product containing only chlorphenamine and paracetamol and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	2
Product containing only dextromethorphan and guaifenesin and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	2
Product containing only hydrocodone and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	2
Product containing only phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	1
Product containing only guaifenesin and phenylephrine and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	2
Guaifenesin and phenylpropanolamine only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	1
Clemastine and phenylpropanolamine only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	2
Product containing only clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	2
Chlorphenamine and mepyramine and phenylephrine and phenylpropanolamine only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	4
Phenylpropanolamine only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	1
Brompheniramine and codeine and phenylpropanolamine only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	2
Product containing only brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	3
Brompheniramine- and codeine- and phenylpropanolamine-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	2
Product containing brompheniramine and codeine and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	2
Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	3
Product containing only brompheniramine and dextromethorphan and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	3
Product containing brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	3
Product containing only brompheniramine and codeine and phenylpropanolamine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	2
Clemastine fumarate 670 microgram and phenylpropanolamine 25 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	1
Clemastine fumarate 670 microgram and phenylpropanolamine 25 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Phenylpropanolamine (substance)	Inferred relationship	Some	1
Adverse reaction to phenylpropanolamine	Causative agent	True	Phenylpropanolamine (substance)	Inferred relationship	Some	1
Product containing precisely chlorphenamine maleate 4 milligram and mepyramine maleate 25 milligram and phenylephrine hydrochloride 10 milligram and phenylpropanolamine 50 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Phenylpropanolamine (substance)	Inferred relationship	Some	2
Product containing precisely chlorphenamine maleate 4 milligram and mepyramine maleate 25 milligram and phenylephrine hydrochloride 10 milligram and phenylpropanolamine 50 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Phenylpropanolamine (substance)	Inferred relationship	Some	2
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Phenylpropanolamine (substance)	Inferred relationship	Some	1

Reference Sets

Description inactivation indicator reference set

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461642010	Phenylpropanolamine (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481555013	Phenylpropanolamine	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4500111000005117	Phenylpropanolamin	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)